Free Trial

Zura Bio (ZURA) Stock Price, News & Analysis

Zura Bio logo
$1.64 -0.04 (-2.38%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.64 0.00 (0.00%)
As of 07/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Zura Bio Stock (NASDAQ:ZURA)

Key Stats

Today's Range
$1.62
$1.75
50-Day Range
$1.00
$1.96
52-Week Range
$0.97
$5.07
Volume
464,497 shs
Average Volume
1.24 million shs
Market Capitalization
$112.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.33
Consensus Rating
Buy

Company Overview

Zura Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

ZURA MarketRank™: 

Zura Bio scored higher than 67% of companies evaluated by MarketBeat, and ranked 354th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zura Bio has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Zura Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Zura Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Zura Bio are expected to decrease in the coming year, from ($0.65) to ($0.78) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zura Bio is -2.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zura Bio is -2.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zura Bio has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Zura Bio's valuation and earnings.
  • Percentage of Shares Shorted

    11.90% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 37.45%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zura Bio does not currently pay a dividend.

  • Dividend Growth

    Zura Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.90% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 37.45%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Zura Bio has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.07 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Zura Bio this week, compared to 2 articles on an average week.
  • Search Interest

    9 people have searched for ZURA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Zura Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zura Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.23% of the stock of Zura Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    61.14% of the stock of Zura Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zura Bio's insider trading history.
Receive ZURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter.

ZURA Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

ZURA Stock Analysis - Frequently Asked Questions

Zura Bio's stock was trading at $2.50 at the beginning of the year. Since then, ZURA stock has decreased by 34.4% and is now trading at $1.64.

Zura Bio Limited (NASDAQ:ZURA) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.02.

Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zura Bio investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Walt Disney (DIS).

Company Calendar

Last Earnings
5/08/2025
Today
7/27/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZURA
CIK
1855644
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
$26.00
Low Price Target
$3.00
Potential Upside/Downside
+774.0%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.39 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-42.84%
Return on Assets
-35.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.14
Quick Ratio
8.14

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.27 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
68,380,000
Free Float
58,645,000
Market Cap
$112.14 million
Optionable
Optionable
Beta
-0.10
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ZURA) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners